September 7 2007  


 

The Dr. Bernard Verbeeten Institute, a major Dutch radiotherapy institute located in Tilburg, will continue to use Oncentra Visir as their record and verify system. “Its flexibility in our mixed-vendor environment perfectly suits our needs for the near future,” says Willy de Kruijf, Medical Physicist at the Dr. Bernard Verbeeten Institute.


The institute is aiming to set up two satellites, offering state-of-the-art treatments to the 1.2 million inhabitants of the Noord-Brabant region. The new configuration, consisting of 5 new Varian linear accelerators and 3 existing Siemens Oncor linear accelerators, will connect Tilburg and the 2 new satellite centers in the nearby cities of ‘s-Hertogenbosch and Breda. This summer the Dr. Bernard Verbeeten Institute announced the order of 5 new Varian linear accelerators. The first one, a Varian Trilogy® equipped with an On-Board Imager®, will be installed at the end of this year in Tilburg. An important new feature, which will be included in the upcoming release 3.0 of Oncentra Visir, is the DCI interface (Device Centric Interface) which facilitates image-guided treatments using DICOM-RT communication with the Varian4D Treatment Console.


Oncentra Visir is part of the Oncentra® software solutions Nucletron provides to radiotherapy clinics. The key benefits of Oncentra Visir are: reduction of total cost of ownership by using one single record and verify system for all linear accelerators from all vendors, increased patient safety due to use of the local language in the user interface, and world class support through local Nucletron branch offices having excellent knowledge of the country and regional specific clinical challenges.


About Nucletron

Established in 1975, Nucletron is a medical device company specializing in the development, production, sales, service and support of some of the world’s most innovative products used in the treatment of cancer. A knowledge-driven leader in Radiation Oncology, Nucletron is committed to working with clinical teams on an individual basis to obtain solutions and systems focused on improving patient care. Headquartered in the Netherlands, Nucletron has offices in 16 countries around the world and delivers tailored services and systems to more than 3,000 institutions across 120 countries. For more information, visit www.nucletron.com



For further information, please contact your Nucletron representative or:

Eric Sewsingh
Product Marketing
Nucletron B.V.                                                  
The Netherlands                                    
Phone: +31 318 557 385                        
Email: Eric.sewsingh@nl.nucletron.com